Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences in October 2019

Logo
Sept. 30, 2019 12:30 UTC

BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that members of the management team will present at the following investor and industry conferences in October:

Cell & Gene Meeting on the Mesa 2019
Corporate presentation
Wednesday, Oct 2nd at 3:15 p.m. Pacific Time
Location: Carlsbad, CA

Panel: What does the future hold for gene editing?
Friday, Oct 4th at 9:45 a.m. Pacific Time
Location: Carlsbad, CA

Cantor Global Healthcare Conference 2019
Friday, Oct 4th at 11:15 a.m. Eastern Time
Location: New York, NY

Chardan 3rd Annual Genetic Medicines Conference
Monday, Oct 7th at 8:30 a.m. Eastern Time
Location: New York, NY

Jefferies Gene Therapy/Editing Summit
Tuesday, Oct 8th at 11:15 a.m. Eastern Time
Location: New York, NY

Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.

Contacts

Investor Relations – Global
McDavid Stilwell
510-970-6000, x219
mstilwell@sangamo.com

Media Inquiries – Global
Aron Feingold
510-970-6000, x421
afeingold@sangamo.com

 

Source: Sangamo Therapeutics, Inc.

Back to news